Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing
September 26, 2024 09:00 ET
|
Psychemedics Corporation
Psychemedics Corporation, a global leader in hair testing for drugs of abuse, announces the release of its first-ever Education Insights Report.
Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing
June 21, 2024 10:00 ET
|
Psychemedics Corporation
Psychemedics Corporation releases its inaugural 2024 Insights Report, offering a comprehensive analysis of workplace drug trends from 2023.
Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
October 27, 2023 11:00 ET
|
Psychemedics Corporation
Psychemedics debuts a 5-panel drug test replacing marijuana with fentanyl, the first hair drug test exclusively targeting the most dire workplace threats.
Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer
September 21, 2023 17:00 ET
|
Psychemedics Corporation
ACTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world’s largest provider of hair testing for drugs of abuse, is pleased to announce the appointment of Shannon...
Psychemedics Announces First Quarter Results
May 13, 2020 17:15 ET
|
Psychemedics Corporation
ACTON, Mass., May 13, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced first quarter financial results for the period ended March 31, 2020. The Company’s revenue for...
Psychemedics Announces a “Vaping Panel” to Detect and Deter the Use of Marijuana, CBD and Nicotine
May 05, 2020 08:00 ET
|
Psychemedics Corporation
ACTON, Mass., May 05, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced a Vaping Panel to...
Psychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDA
April 29, 2020 12:00 ET
|
Psychemedics Corporation
ACTON, Mass., April 29, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the first...
Psychemedics Corporation Announces 4th Quarter and Year-End Results
February 11, 2020 17:25 ET
|
Psychemedics Corporation
ACTON, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2019. The...
Psychemedics Corporation Announces New Brazilian Distribution Agreement
September 19, 2019 17:25 ET
|
Psychemedics Corporation
ACTON, Mass., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (Nasdaq:PMD) announced today that it has entered into a new distribution agreement in Brazil with Sansão Holding S.A. and...
Psychemedics Announces Second Quarter Results and Declares 92nd Consecutive Quarterly Dividend
July 23, 2019 17:25 ET
|
Psychemedics Corporation
ACTON, Mass., July 23, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced second quarter financial results for the period ended June 30, 2019. The Company also announced...